Thank you for your email which has been noted. The Secretariat are dealing
with a large volume of queries concerning the advice of JCVI and will
endeavour to respond to your queries on this. Your patience is gratefully
appreciated.

JCVI continues to work on providing advice to UK Government on the use of
COVID-19 vaccines in the UK. Further advice will be published when
prepared.

All of JCVI’s advice can be found using the following link, and are listed
below https://www.gov.uk/search/all?keywords=J...

Minutes of JCVI meetings can be found at:
https://app.box.com/s/iddfb4ppwkmtjusir2tc

Further detail on the COVID-19 vaccination programme is available from the
Green Book immunisation against infectious Disease chapter on COVID-19 at:
https://www.gov.uk/government/publicatio...

JCVI statements relevant to COVID-19

• JCVI statement on immunisation prioritisation - GOV.UK (www.gov.uk)
• [Withdrawn] JCVI: updated interim advice on priority groups for COVID-19
vaccination - GOV.UK (www.gov.uk)
• Independent report overview: Priority groups for coronavirus (COVID-19)
vaccination: advice from the JCVI, 2 December 2020 - GOV.UK (www.gov.uk)
• Priority groups for coronavirus (COVID-19) vaccination: advice from the
JCVI, 30 December 2020 - GOV.UK (www.gov.uk)
• Prioritising the first COVID-19 vaccine dose: JCVI statement - GOV.UK
(www.gov.uk)
• JCVI interim statement on phase 2 of the COVID-19 vaccination programme:
26 February 2021 - GOV.UK (www.gov.uk)
• Letter from the Health and Social Care Secretary on COVID-19 vaccination
phase 1 advice - GOV.UK (www.gov.uk)
• JCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021
- GOV.UK (www.gov.uk)
• Use of the AstraZeneca COVID-19 vaccine: JCVI statement, 7 May 2021 -
GOV.UK (www.gov.uk)
• JCVI issues new advice on COVID-19 vaccination for pregnant women -
GOV.UK (www.gov.uk)
• Priority groups for phase 2 of the coronavirus (COVID-19) vaccination
programme: advice from the JCVI - GOV.UK (www.gov.uk)
• Annex A: COVID-19 vaccine allocation by occupation in those under than
50 years of age: considerations for prioritisation and allocation - GOV.UK
(www.gov.uk)
• Letter from the Health and Social Care Secretary on COVID-19 vaccination
in people with learning disabilities - GOV.UK (www.gov.uk)
• JCVI interim advice on a potential coronavirus (COVID-19) booster
vaccine programme for winter 2021 to 2022 - GOV.UK (www.gov.uk)
• COVID-19 vaccination of children and young people aged 12 to 17 years:
JCVI statement - GOV.UK (www.gov.uk)
• JCVI statement, August 2021: COVID-19 vaccination of children and young
people aged 12 to 17 years - GOV.UK (www.gov.uk)
• JCVI statement, September 2021: COVID-19 booster vaccine programme for
winter 2021 to 2022 - GOV.UK (www.gov.uk)
• JCVI statement, September 2021: COVID-19 vaccination of children aged 12
to 15 years - GOV.UK (www.gov.uk)
• COVID-19 vaccination in children and young people aged 16 to 17 years:
JCVI statement, November 2021 - GOV.UK (www.gov.uk)
• Third primary COVID-19 vaccine dose for people who are immunosuppressed:
JCVI advice - GOV.UK (www.gov.uk)
• COVID-19 booster vaccine programme for winter 2021 to 2022: JCVI
statement, November 2021 - GOV.UK (www.gov.uk)
• UK vaccine response to the Omicron variant: JCVI advice - GOV.UK
(www.gov.uk)
• JCVI update on advice for COVID-19 vaccination of children and young
people - GOV.UK (www.gov.uk)

show quoted sections

Dear Kenneth MacArthur,

Your request will be handled by the Information Rights Team at the UK
Health Security Agency (UKHSA). We acknowledge receipt of your email and
request for information, which will be treated as a request for
information under statutory access legislation. UKHSA has taken
responsibility for statutory access requests addressed to Public Health
England and NHS Test and Trace Services.

Please note that requests under the Freedom of Information Act and the
Environmental Information Regulations (EIRs) will receive a response
within 20 working days from the day following the date of receipt of your
request.

If the request is for your personal data, your request will be handled as
a data subject access request (SAR) under Article 15 of the General Data
Protection Regulation (GDPR), then we will respond within one month of the
receipt of the request.

The UK Health Security Agency is heavily involved in the government’s
response to the COVID-19 pandemic. We will aim to address all requests
promptly and within the required response timeframes.  However, when we
are unable to meet the response timeframe we will keep requesters updated
on a revised expected timescale for a response to their request. The
Information Commissioner recognises this position in its recent guidance,
see link:
[1]https://ico.org.uk/media/2617613/ico-reg...

Yours sincerely,
Information Rights Team
UK Health Security Agency
[2][email address] 
[3]www.gov.uk/ukhsa  Follow us on Twitter @UKHSA

══════════════════════════════════════════════════════════════════════════

From: FOI <[email address]>
Sent: 03 May 2022 09:13
To: Information Rights <[email address]>
Subject: FW: OFFICIAL: FW: Freedom of Information request - Advice on use
of Novavax COVID-19 vaccine (Nuvaxovid)

show quoted sections

Dear Kenneth MacArthur,

Please find attached the UK Health Security Agency's response to your
request. 

Yours sincerely,
Information Rights Team
UK Health Security Agency
[1][email address] 
[2]www.gov.uk/ukhsa  Follow us on Twitter @UKHSA

══════════════════════════════════════════════════════════════════════════

show quoted sections